Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 32: 1473-1476, 1986;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parker, N. C.
Right arrow Articles by Chapman, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parker, N. C.
Right arrow Articles by Chapman, J. F.

Clinical Chemistry, Vol 32, 1473-1476, Copyright © 1986 by American Association for Clinical Chemistry

Uniform chromatographic conditions for quantifying urinary catecholamines, metanephrines, vanillylmandelic acid, 5- hydroxyindoleacetic acid, by liquid chromatography, with electrochemical detection

NC Parker, CB Levtzow, PW Wright, LL Woodard and JF Chapman

Uniform liquid-chromatographic conditions were developed such that we could quantify norepinephrine, epinephrine, normetanephrine, metanephrine, vanillylmandelic acid, and 5-hydroxyindoleacetic acid in urine by using a single mobile phase of monochloroacetic acid and citric acid, 0.1 mol/L each. All compounds were separated on a C18 column and detected electrochemically at a potential of +0.800 V. Optimization of these uniform chromatographic conditions significantly shortens the changeover time required from one assay to another, resulting in a substantial savings of time and cost to the laboratory.


The following articles in journals at HighWire Press have cited this article:


Home page
J. Pharmacol. Exp. Ther.Home page
J. Riba, M. Valle, G. Urbano, M. Yritia, A. Morte, and M. J. Barbanoj
Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics
J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 73 - 83.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. J. Panholzer, J. Beyer, and K. Lichtwald
Coupled-Column Liquid Chromatographic Analysis of Catecholamines, Serotonin, and Metabolites in Human Urine
Clin. Chem., February 1, 1999; 45(2): 262 - 268.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Association for Clinical Chemistry.